High versus low frequency transcutaneous acupoint electrical stimulation as an adjunct therapy to prevent nausea and vomiting in the first 24 hours after infusion of high-grade emetic chemotherapy: A randomized controlled trial
DOI:
https://doi.org/10.33233/fb.v24i2.5136Keywords:
Antineoplastic combined chemotherapy protocols, antiemetic agents, electrical stimulation therapy, acupunctureAbstract
Background: Transcutaneous acupoint electrical stimulation (TAES) has been tested as antiemetic therapy. Objective: Evaluation of the effectiveness of two different frequencies of the electrical current as adjunctive therapy in the prevention of nausea and vomiting. Methods: This placebo-controlled clinical trial compared the incidence of nausea and vomiting (within the first 24 hours after high-grade emetic chemotherapy infusion) of 61 women (54 ± 11 years) with breast cancer undergoing three modes of TAES: high frequency (HF:150 Hz), low frequency (LF:10 Hz), and placebo (P). Electrodes were fixed at the acupuncture point PC6 and a symmetric bipolar current (pulse width 200 μs) was applied in a single 30-minute session prior to the start of chemotherapy infusion. All patients receive fixed antiemetic treatment infusions (ondansetron 8 mg) and rescue medication instructions, if necessary, according to the routine for infusions of cyclophosphamide associated with anthracycline. Results: The incidence of nausea was 47% in P, 45% in HF and 26% in LF. Although not significant, the intervention with LF-TAES at PC6 acupoint reached relevant values in reducing the relative risk of developing nausea (RR = 0.51; CI 95% = 0.18 to 1.44; p = 0.18) and a trend toward improved reported well-being (p = 0.06) and a lower Edmonton Symptom Rating Scale score (p = 0.08). The incidence of vomiting and the consumption of rescue antiemetic doses were very similar between the groups. Conclusion: New studies with LF and HF of TAES as adjuvant therapy for the prevention of nausea and vomiting should be carried out to confirm this hypothesis.
References
Herrstedt J, Roila F, Warr D, Celio L, Navari RM, Hesketh PJ, Chan A, Aapro MS. 2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy. Support Care Cancer. 2017 Jan;25(1):277-88. doi: 10.1007/s00520-016-3313-0
Rapoport B, Schwartzberg L, Chasen M, Powers D, Arora S, Navari R, Schnadig I. Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy. Eur J Cancer. 2016 Apr;57:23-30. doi: 10.1016/j.ejca.2015.12.023
Ozgür TM, Sandıkçı Z, Uygur MC, Arık AI, Erol D. Combination of transcutaneous electrical nerve stimulation and ondansetron in preventing cisplatin-induced emesis. Urol Int. 2001;67(1):54-8. doi: 10.1159/000050945
Dou P-H, Zhang D-F, Su C-H, Zhang X-L, Wu Y-J. Electrical stimulation on adverse events caused by chemotherapy in patients with cervical cancer: A protocol for a systematic review of randomized controlled trial. Medicine (Baltimore). 2019 Feb;98(7):e14609. doi: 10.1097/MD.0000000000014609
Lee A, Done ML. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. The Cochrane database of systematic reviews. 2004;(3):CD003281. doi: 10.1002/14651858.CD003281.pub3
Lee A, Fan LT. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane database of Syst Rev. 2009 April 15;(2):CD003281. doi: 10.1002/14651858.CD003281.pub3
Lee A, Chan SKC, Fan LTY. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane database Syst Rev. 2015 Nov 2;2015(11):CD003281. doi: 10.1002/14651858.CD003281.pub4
Cui Y, Wang L, Shi G, Lui L, Pei P, Guo J. Electroacupuncture alleviates cisplatin-induced nausea in rats. Acupunct Med. 2016 Apr;34(2):120-6. doi: 10.1136/acupmed-2015-010833
Xie J, Chen L-H, Ning Z-Y, Zhang C-Y, Chen H, Chen Z, et al. Effect of transcutaneous electrical acupoint stimulation combined with palonosetron on chemotherapy-induced nausea and vomiting: a single-blind, randomized, controlled trial. Chin J Cancer. 2017;36(6). doi: 10.1186/s40880-016-0176-1
McKeon C, Smith CA, Gibbons K, Hardy J. Electro Acupuncture versus sham acupuncture and no acupuncture for the control of acute and delayed chemotherapy-induced nausea and vomiting: a pilot study. Acupunct Med. 2015 Aug;33(4):277-83. doi: 10.1136/acupmed-2015-010781
Chen B, Hu S, Liu B, Zhao T, Li B, Liu Y, et al. Efficacy and safety of electroacupuncture with different acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial. Trials. 2015 May;16:212. doi: 10.1186/s13063-015-0734-x
Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol Off J Eur Soc Med Oncol. 2010 May;21 Suppl 5:v232-43. doi: 10.1093/annonc/mdq194
Bruela E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method of the assessment of palliative care patients. J Palliat Care. 1991;2(7):6-9. https://pubmed.ncbi.nlm.nih.gov/1714502/
Herrstedt J. The latest consensus on antiemetics. Curr Opin Oncol. 2018 Jul;30(4):233-39. doi: 10.1097/CCO.0000000000000450
Zhang Z, Zhang Y, Chen G, Hong S, Yang Y, Fang W, Luo F, Chen X, Ma Y, Zhao Y, Zhan J, Xue C, Hou X, Zhou T, Ma S, Gao F, Huang Y, Chen L, Zhou N, Zhao H, Zhang Li. Olanzapine-based triple regimens versus neurokinin-1 receptor antagonist-based triple regimens in preventing chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy: a network meta-analysis . Oncologist 2018 May;23(5):603-16. doi: 10.1634/theoncologist.2017-0378
Ezzo J, Vickers A, Richardson MA, Allen C, Dibble SL, Issell B, Lao L, Pearl M, Ramirez G, Roscoe AJ, Shen J, Shivnan J, Streitberger K, Treish I, Zhang G. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol. 2005 Oct 1;23(28):7188-98. doi: 10.1002/14651858.CD002285.pub2
Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl P, Ramirez G, Roscoe Ja, Shen J, Shivnan JC, Streitberger K, Treish I. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002285. doi: 10.1002/14651858.CD002285.pub2
Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci. 2003 Jan;26(1):17-22. doi: 10.1016/s0166-2236(02)00006-
Chen H-Y, Li S-G, Cho WC, Zhang Z-J. The role of acupoint stimulation as an adjunct therapy for lung cancer: a systematic review and meta-analysis. BMC Complement Altern Med. 2013 Dec 17;13:362. doi: 10.1186/1472-6882-13-362
Published
Issue
Section
License
Copyright (c) 2023 Rafael Ailton Fattori, Júlia Schlöttgen, Fernanda Laís Loro, Pauline Lopes Carvalho, Rodrigo Orso, Fabricio Edler Macagnan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are authorized for non-exclusive distribution of the version of the work published in this journal (eg, publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
